Living Guidelines

Recommendations cover:

Autosomal dominant polycystic kidney disease

• Tolvaptan in the management of ADPKD (available for public comment)
• Fluid intake and ketogenic diets (available for public comment)

Cardiovascular disease management in chronic kidney disease

• Cholesterol-lowering therapy
• SGLT2 inhibitors (available for public comment)

Urate-lowering therapy

Recommendations:

Haemodialysis 

Recommendations:

Kidney transplantantation

Recommendations: